Cargando…

A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial

Detalles Bibliográficos
Autores principales: Nathan, Steven D., Medarov, Boris, Ho, Lawrence, Kingrey, John, Hong, Taekwon, Rao, Youlan, Shen, Eric, Smith, Peter, Deng, Chunqin, Waxman, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559141/
https://www.ncbi.nlm.nih.gov/pubmed/37413676
http://dx.doi.org/10.1513/AnnalsATS.202303-229RL
_version_ 1785117432665341952
author Nathan, Steven D.
Medarov, Boris
Ho, Lawrence
Kingrey, John
Hong, Taekwon
Rao, Youlan
Shen, Eric
Smith, Peter
Deng, Chunqin
Waxman, Aaron
author_facet Nathan, Steven D.
Medarov, Boris
Ho, Lawrence
Kingrey, John
Hong, Taekwon
Rao, Youlan
Shen, Eric
Smith, Peter
Deng, Chunqin
Waxman, Aaron
author_sort Nathan, Steven D.
collection PubMed
description
format Online
Article
Text
id pubmed-10559141
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-105591412023-10-08 A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial Nathan, Steven D. Medarov, Boris Ho, Lawrence Kingrey, John Hong, Taekwon Rao, Youlan Shen, Eric Smith, Peter Deng, Chunqin Waxman, Aaron Ann Am Thorac Soc Letters American Thoracic Society 2023-10-01 /pmc/articles/PMC10559141/ /pubmed/37413676 http://dx.doi.org/10.1513/AnnalsATS.202303-229RL Text en Copyright © 2023 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern.
spellingShingle Letters
Nathan, Steven D.
Medarov, Boris
Ho, Lawrence
Kingrey, John
Hong, Taekwon
Rao, Youlan
Shen, Eric
Smith, Peter
Deng, Chunqin
Waxman, Aaron
A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
title A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
title_full A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
title_fullStr A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
title_full_unstemmed A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
title_short A Novel Approach to Clinical Change Endpoints: A Win Ratio Analysis of the INCREASE Trial
title_sort novel approach to clinical change endpoints: a win ratio analysis of the increase trial
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559141/
https://www.ncbi.nlm.nih.gov/pubmed/37413676
http://dx.doi.org/10.1513/AnnalsATS.202303-229RL
work_keys_str_mv AT nathanstevend anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT medarovboris anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT holawrence anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT kingreyjohn anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT hongtaekwon anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT raoyoulan anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT sheneric anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT smithpeter anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT dengchunqin anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT waxmanaaron anovelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT nathanstevend novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT medarovboris novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT holawrence novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT kingreyjohn novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT hongtaekwon novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT raoyoulan novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT sheneric novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT smithpeter novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT dengchunqin novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial
AT waxmanaaron novelapproachtoclinicalchangeendpointsawinratioanalysisoftheincreasetrial